| Michael Lynn Snarr, DO | |
|
820 E 17th St, Cheyenne, WY 82001-4714 | |
| (307) 632-2434 | |
| Not Available |
| Full Name | Michael Lynn Snarr |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 7 Years |
| Location | 820 E 17th St, Cheyenne, Wyoming |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1851821995 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 132-T2 (Wyoming) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Community Hospital | Torrington, WY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Community Hospital | 6608784194 | 26 |
News Archive
The National Coalition for Cancer Survivorship announced its support of the two final rules issued by the Centers for Medicare and Medicaid Services and the Office of the National Coordinator for Health Information Technology for the electronic health record incentive programs at a briefing hosted by the U.S. Department of Health and Human Services today.
For decades, immunologists have been trying to train the transplant recipient's immune system to accept transplanted cells and organs without the long-term use of anti-rejection drugs. New University of Minnesota preclinical research shows that this is now possible.
The Wyss Institute for Biologically Inspired Engineering at Harvard University has entered into a collaboration with ReWalk Robotics Ltd., to accelerate the development of the Institute's lightweight, wearable soft exosuit technologies for assisting people with lower limb disabilities.
The U.S. Food and Drug Administration today approved Teflaro (ceftaroline fosamil), an injectable antibiotic to treat adults with community acquired bacterial pneumonia (CABP) and acute bacterial skin and skin structure infections (ABSSSI), including methicillin-resistant Staphylococcus aureus (MRSA).
New findings from the Monell Center reveal that weight gain of formula-fed infants is influenced by the type of formula the infant is consuming. The findings have implications related to the infant's risk for the development of obesity, diabetes and other diseases later in life.
› Verified 1 days ago
| Entity Name | Platte County Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265469506 PECOS PAC ID: 6709798150 Enrollment ID: O20031104000172 |
News Archive
The National Coalition for Cancer Survivorship announced its support of the two final rules issued by the Centers for Medicare and Medicaid Services and the Office of the National Coordinator for Health Information Technology for the electronic health record incentive programs at a briefing hosted by the U.S. Department of Health and Human Services today.
For decades, immunologists have been trying to train the transplant recipient's immune system to accept transplanted cells and organs without the long-term use of anti-rejection drugs. New University of Minnesota preclinical research shows that this is now possible.
The Wyss Institute for Biologically Inspired Engineering at Harvard University has entered into a collaboration with ReWalk Robotics Ltd., to accelerate the development of the Institute's lightweight, wearable soft exosuit technologies for assisting people with lower limb disabilities.
The U.S. Food and Drug Administration today approved Teflaro (ceftaroline fosamil), an injectable antibiotic to treat adults with community acquired bacterial pneumonia (CABP) and acute bacterial skin and skin structure infections (ABSSSI), including methicillin-resistant Staphylococcus aureus (MRSA).
New findings from the Monell Center reveal that weight gain of formula-fed infants is influenced by the type of formula the infant is consuming. The findings have implications related to the infant's risk for the development of obesity, diabetes and other diseases later in life.
› Verified 1 days ago
| Entity Name | Medi Horizons Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154342921 PECOS PAC ID: 6305750134 Enrollment ID: O20031117000449 |
News Archive
The National Coalition for Cancer Survivorship announced its support of the two final rules issued by the Centers for Medicare and Medicaid Services and the Office of the National Coordinator for Health Information Technology for the electronic health record incentive programs at a briefing hosted by the U.S. Department of Health and Human Services today.
For decades, immunologists have been trying to train the transplant recipient's immune system to accept transplanted cells and organs without the long-term use of anti-rejection drugs. New University of Minnesota preclinical research shows that this is now possible.
The Wyss Institute for Biologically Inspired Engineering at Harvard University has entered into a collaboration with ReWalk Robotics Ltd., to accelerate the development of the Institute's lightweight, wearable soft exosuit technologies for assisting people with lower limb disabilities.
The U.S. Food and Drug Administration today approved Teflaro (ceftaroline fosamil), an injectable antibiotic to treat adults with community acquired bacterial pneumonia (CABP) and acute bacterial skin and skin structure infections (ABSSSI), including methicillin-resistant Staphylococcus aureus (MRSA).
New findings from the Monell Center reveal that weight gain of formula-fed infants is influenced by the type of formula the infant is consuming. The findings have implications related to the infant's risk for the development of obesity, diabetes and other diseases later in life.
› Verified 1 days ago
| Entity Name | Community Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669410643 PECOS PAC ID: 6608784194 Enrollment ID: O20040127001124 |
News Archive
The National Coalition for Cancer Survivorship announced its support of the two final rules issued by the Centers for Medicare and Medicaid Services and the Office of the National Coordinator for Health Information Technology for the electronic health record incentive programs at a briefing hosted by the U.S. Department of Health and Human Services today.
For decades, immunologists have been trying to train the transplant recipient's immune system to accept transplanted cells and organs without the long-term use of anti-rejection drugs. New University of Minnesota preclinical research shows that this is now possible.
The Wyss Institute for Biologically Inspired Engineering at Harvard University has entered into a collaboration with ReWalk Robotics Ltd., to accelerate the development of the Institute's lightweight, wearable soft exosuit technologies for assisting people with lower limb disabilities.
The U.S. Food and Drug Administration today approved Teflaro (ceftaroline fosamil), an injectable antibiotic to treat adults with community acquired bacterial pneumonia (CABP) and acute bacterial skin and skin structure infections (ABSSSI), including methicillin-resistant Staphylococcus aureus (MRSA).
New findings from the Monell Center reveal that weight gain of formula-fed infants is influenced by the type of formula the infant is consuming. The findings have implications related to the infant's risk for the development of obesity, diabetes and other diseases later in life.
› Verified 1 days ago
| Entity Name | Washakie Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255368593 PECOS PAC ID: 2466369301 Enrollment ID: O20040312000646 |
News Archive
The National Coalition for Cancer Survivorship announced its support of the two final rules issued by the Centers for Medicare and Medicaid Services and the Office of the National Coordinator for Health Information Technology for the electronic health record incentive programs at a briefing hosted by the U.S. Department of Health and Human Services today.
For decades, immunologists have been trying to train the transplant recipient's immune system to accept transplanted cells and organs without the long-term use of anti-rejection drugs. New University of Minnesota preclinical research shows that this is now possible.
The Wyss Institute for Biologically Inspired Engineering at Harvard University has entered into a collaboration with ReWalk Robotics Ltd., to accelerate the development of the Institute's lightweight, wearable soft exosuit technologies for assisting people with lower limb disabilities.
The U.S. Food and Drug Administration today approved Teflaro (ceftaroline fosamil), an injectable antibiotic to treat adults with community acquired bacterial pneumonia (CABP) and acute bacterial skin and skin structure infections (ABSSSI), including methicillin-resistant Staphylococcus aureus (MRSA).
New findings from the Monell Center reveal that weight gain of formula-fed infants is influenced by the type of formula the infant is consuming. The findings have implications related to the infant's risk for the development of obesity, diabetes and other diseases later in life.
› Verified 1 days ago
| Entity Name | Community Hospital |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1669410643 PECOS PAC ID: 6608784194 Enrollment ID: O20061104000311 |
News Archive
The National Coalition for Cancer Survivorship announced its support of the two final rules issued by the Centers for Medicare and Medicaid Services and the Office of the National Coordinator for Health Information Technology for the electronic health record incentive programs at a briefing hosted by the U.S. Department of Health and Human Services today.
For decades, immunologists have been trying to train the transplant recipient's immune system to accept transplanted cells and organs without the long-term use of anti-rejection drugs. New University of Minnesota preclinical research shows that this is now possible.
The Wyss Institute for Biologically Inspired Engineering at Harvard University has entered into a collaboration with ReWalk Robotics Ltd., to accelerate the development of the Institute's lightweight, wearable soft exosuit technologies for assisting people with lower limb disabilities.
The U.S. Food and Drug Administration today approved Teflaro (ceftaroline fosamil), an injectable antibiotic to treat adults with community acquired bacterial pneumonia (CABP) and acute bacterial skin and skin structure infections (ABSSSI), including methicillin-resistant Staphylococcus aureus (MRSA).
New findings from the Monell Center reveal that weight gain of formula-fed infants is influenced by the type of formula the infant is consuming. The findings have implications related to the infant's risk for the development of obesity, diabetes and other diseases later in life.
› Verified 1 days ago
| Entity Name | Banner Health Physicians West Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063778728 PECOS PAC ID: 5092978866 Enrollment ID: O20120607000123 |
News Archive
The National Coalition for Cancer Survivorship announced its support of the two final rules issued by the Centers for Medicare and Medicaid Services and the Office of the National Coordinator for Health Information Technology for the electronic health record incentive programs at a briefing hosted by the U.S. Department of Health and Human Services today.
For decades, immunologists have been trying to train the transplant recipient's immune system to accept transplanted cells and organs without the long-term use of anti-rejection drugs. New University of Minnesota preclinical research shows that this is now possible.
The Wyss Institute for Biologically Inspired Engineering at Harvard University has entered into a collaboration with ReWalk Robotics Ltd., to accelerate the development of the Institute's lightweight, wearable soft exosuit technologies for assisting people with lower limb disabilities.
The U.S. Food and Drug Administration today approved Teflaro (ceftaroline fosamil), an injectable antibiotic to treat adults with community acquired bacterial pneumonia (CABP) and acute bacterial skin and skin structure infections (ABSSSI), including methicillin-resistant Staphylococcus aureus (MRSA).
New findings from the Monell Center reveal that weight gain of formula-fed infants is influenced by the type of formula the infant is consuming. The findings have implications related to the infant's risk for the development of obesity, diabetes and other diseases later in life.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michael Lynn Snarr, DO 820 E 17th St, Cheyenne, WY 82001-4714 Ph: (307) 632-2434 | Michael Lynn Snarr, DO 820 E 17th St, Cheyenne, WY 82001-4714 Ph: (307) 632-2434 |
News Archive
The National Coalition for Cancer Survivorship announced its support of the two final rules issued by the Centers for Medicare and Medicaid Services and the Office of the National Coordinator for Health Information Technology for the electronic health record incentive programs at a briefing hosted by the U.S. Department of Health and Human Services today.
For decades, immunologists have been trying to train the transplant recipient's immune system to accept transplanted cells and organs without the long-term use of anti-rejection drugs. New University of Minnesota preclinical research shows that this is now possible.
The Wyss Institute for Biologically Inspired Engineering at Harvard University has entered into a collaboration with ReWalk Robotics Ltd., to accelerate the development of the Institute's lightweight, wearable soft exosuit technologies for assisting people with lower limb disabilities.
The U.S. Food and Drug Administration today approved Teflaro (ceftaroline fosamil), an injectable antibiotic to treat adults with community acquired bacterial pneumonia (CABP) and acute bacterial skin and skin structure infections (ABSSSI), including methicillin-resistant Staphylococcus aureus (MRSA).
New findings from the Monell Center reveal that weight gain of formula-fed infants is influenced by the type of formula the infant is consuming. The findings have implications related to the infant's risk for the development of obesity, diabetes and other diseases later in life.
› Verified 1 days ago
Dr. Kristine K Van Kirk, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 6015 Sycamore Rd, Cheyenne, WY 82009 Phone: 307-823-2968 | |
Dr. Christian Alexander Flanders, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 820 E 17th St, Cheyenne, WY 82001 Phone: 307-632-2434 Fax: 307-634-3510 | |
Dr. Bradley Mohar, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 214 E 23rd St, Cheyenne, WY 82001 Phone: 307-634-2273 | |
Dr. Douglas W Edgren, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1331 Prairie Ave Ste 1, Cheyenne, WY 82009 Phone: 307-632-0728 | |
Zachary Dale Herman, Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 820 E 17th St, Cheyenne, WY 82001 Phone: 307-632-2434 Fax: 307-635-3510 | |
Margaret Ann Lembitz, NP Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 3229 E Pershing Blvd, Cheyenne, WY 82001 Phone: 307-363-2054 Fax: 307-227-6817 | |
Benjamin Leishman, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 820 E 17th St, Cheyenne, WY 82001 Phone: 307-632-2434 |